PER 0.00% 10.0¢ percheron therapeutics limited

Taylor iniitates coverage of ANP with SP target of $0.27 undiluted, page-2

  1. 420 Posts.
    lightbulb Created with Sketch. 471
    I will read in detail over the weekend. A bit to digest. Must admit I went straight to the last page (disclaimer) to see if it was paid research. Seems like it isn't, but others may pick up on something I missed. A good sign.
    I have no objection to the valuation as a significant discount was used in all calculations, whereas the actual outcomes will be binary. Additionally, the valuation as only for ATL1102 in DMD. And a small bit of the voucher. Word is getting out...
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.